Medicinal Chemistry

Synthesis and evaluation of novel dual GSK-3β/HDAC inhibitor as an anti-Alzheimer agent.

To investigate

Novel synthesis of flavonoid-hydroxypyridinone hybrids as potential anti-Alzheimer agents.

Exploration of oxadiazole scaffolds into potential pan peroxisome proliferator-activated receptors (PPARs) agonists as antidiabetic agents

Development of modified kynurenic acid-based scaffolds for treatment of post-traumatic stress disorder

Designing of senolytic agents for the treatment of Alzheimers disease

Development of SOPs and Standardization of Different Preparation Techniques of Netra Putapaka Formulation for Ophthalmic Use

Design, synthesis, and evaluation of novel heterocyclic scaffolds as potential antidiabetic agents targeted to PPAR alpha gamma dual agonist

Discovering the anti-inflammatory effects of novel Toll-like receptor signaling inhibitors on rheumatoid arthritis mononuclear cells and synovial fibroblasts- An in vitro study to identify TLR signaling inhibition in rheumatoid arthritis

Exploring the immunomodulatory activities of novel Toll-like receptor-signaling inhibitors in peripheral blood mononuclear cells from lupus patients: A study to identify TLRs as drug targets for lupus

Aminoglycoside (Tobramycin) Based HybridSmall Molecules Targeting Bacterial rRNA A-site for Developing New AntitubercularAgents